SELLAS Life Sciences Group Inc (NASDAQ:SLS) price on Wednesday, April 30, rose 8.39% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.55.
A look at the stock’s price movement, the close in the last trading session was $1.43, moving within a range at $1.3818 and $1.55. The beta value (5-Year monthly) was 2.54. Turning to its 52-week performance, $1.84 and $0.77 were the 52-week high and 52-week low respectively. Overall, SLS moved 43.52% over the past month.
SELLAS Life Sciences Group Inc’s market cap currently stands at around $146.55 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-19.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SLS is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend SLS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SLS’s current price about 25.46% and 29.19% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 80.15, while 7-day volatility ratio is 8.59% and 7.90% in the 30-day chart. Further, SELLAS Life Sciences Group Inc (SLS) has a beta value of 2.36, and an average true range (ATR) of 0.10. Analysts have given the company’s stock an average 52-week price target of $2.8, forecast between a low of $2.4 and high of $3.2. Looking at the price targets, the low is -54.84% off current price level while to achieve the yearly target high, price needs to move -106.45%. Nonetheless, investors will most likely welcome a -80.65% jump to $2.8 which is the analysts’ median price.
If we refocus on SELLAS Life Sciences Group Inc (NASDAQ:SLS), historical trading data shows that trading volumes averaged 1.88 over the past 10 days and 1.58 million over the past 3 months. The company’s latest data on shares outstanding shows there are 94.55 million shares.
The 2.08% of SELLAS Life Sciences Group Inc’s shares are in the hands of company insiders while institutional holders own 6.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.77 million on 2025-04-15, giving us a short ratio of 7.59. The data shows that as of 2025-04-15 short interest in SELLAS Life Sciences Group Inc (SLS) stood at 857.0 of shares outstanding, with shares short falling to 7.85 million registered in 2025-03-14. Current price change has pushed the stock 49.04% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SLS stock continues to rise going into the next quarter.
